Trials / Completed
CompletedNCT04597502
The Effects of Terminalia Chebula Fruit Extract on the Gut Microbiome and Skin Biophysical Properties
"The Effects of Synastol TC (Standardized Terminalia Chebula Fruit Extract) on the Gut Microbiome and Skin Biophysical Properties"
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Integrative Skin Science and Research · Industry
- Sex
- Female
- Age
- 25 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the use of oral Terminalia chebula fruit extract on the gut microbiome and skin biophysical properties. The fruit is commonly used for skin treatments in India. It is thought to have antioxidant properties, reduce inflammation and affect the microorganisms in the gut. The information the investigators will learn from this study may indicate how and if oral dosing can affect the skin and gut microbiome. This may lead to an improved understanding of the skin and determine whether these oral products are effective for improving the skin's appearance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Terminalia Chebula fruit extract | Oral TC fruit extract supplement taken by mouth twice per day |
| DIETARY_SUPPLEMENT | Placebo | Oral placebo taken by mouth twice per day |
| OTHER | Topical Terminalia Chebula | Applied to both forearms and dorsal hands |
| OTHER | Topical Placebo | Applied to both forearms and dorsal hands |
Timeline
- Start date
- 2020-10-15
- Primary completion
- 2022-03-29
- Completion
- 2022-09-01
- First posted
- 2020-10-22
- Last updated
- 2022-11-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04597502. Inclusion in this directory is not an endorsement.